3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
4
Neoplasms
3
Breast Neoplasms
3
Papillomavirus Infections
2
Lung Neoplasms
2
Uterine Cervical Diseases
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Pulmonary Atelectasis
1
Postural Orthostatic Tachycardia Syndrome
1
Postoperative Complications
1
Pneumonia
1
Pancreatic carcinoma, familial
1
Pancreatic cancer, adult
1
Multiple Myeloma
1
Mastocytosis
1
Lung Cancer Screening
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
HIV Infections
1
Financial Stress
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cervical Cancer Screening
1
Bronchopulmonary Disease
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
durvalumab
13
Bevacizumab
11
Nivolumab
10
tremelimumab
7
pembrolizumab
6
lenvatinib
6
fludarabine
6
Cyclophosphamide
6
atezolizumab
4
Radiosurgery
4
Cisplatin
4
toripalimab
3
relatlimab
3
Magnetic Resonance Imaging
3
Ipilimumab
3
Gemcitabine
3
X-Rays
2
Standard of Care
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Photons
2
Patient Navigation
2
Lidocaine
2
Hepatectomy
2
Dexamethasone
2
Biopsy
2
trastuzumab deruxtecan
1
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Mass Screening
×
1 year
×
Clear all
No trials found.